Pricing Log in Create free account

Edesa Biotech, Inc. (EDSA) vs Cassava Sciences, Inc. (FLNA)

Edesa Biotech, Inc. and Cassava Sciences, Inc. are both Biotechnology companies. Edesa Biotech, Inc. and Cassava Sciences, Inc. are of similar size ($36.8M and $36.1M). Cassava Sciences, Inc. grew revenue faster over the last twelve months: 277.6% against −43.5%. Across the 9 metrics below, Cassava Sciences, Inc. leads on 5 and Edesa Biotech, Inc. on 4.

Valuation

Metric EDSA FLNA Biotechnology median
P/E n/m n/m 8.50
P/S 70.40 n/m 9.71
P/B 58.02 0.54 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.08 0.64
EV/Sales 38.98 n/m 9.21
Earnings yield (65.76%) (122.54%) (33.15%)
Free cash flow yield (38.51%) (85.60%) (25.50%)

Profitability

Metric EDSA FLNA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (531.32%) (55.78%) (56.36%)
Return on assets (102.46%) (35.34%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDSA FLNA Biotechnology median
Revenue growth (TTM) (43.48%) 277.58% 6.02%
EPS growth (last fiscal year) 34.20% (259.95%) 30.26%
Revenue growth, 5-year CAGR (15.40%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDSA FLNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.76 2.08 4.72
Net debt to EBITDA 1.39 1.01 0.96

Dividend

Metric EDSA FLNA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EDSA FLNA Biotechnology median
Market cap 36.08m 36.75m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack